Grid-derived structure-based 3D pharmacophores and their performance compared to docking

Drug Discovery Today: Technologies

Volumn 7, Issue 4, 2010, Pages

  Cross, Simon ^a   Cruciani, Gabriele ^b  

^a Molecular Discovery Limited   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER AIDED DESIGN; DRUG DESIGN; METABOLISM; MOLECULAR DOCKING; PHARMACOPHORE; SCREENING TEST; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRTUAL SCREENING;

EID: 78650750776     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.09.002     Document Type: Review

References (33)

1. J.H. Van Drie Monty Kier and the origin of the pharmacophore concept Internet Electron. J. Mol. Des. 6 2007 271 279
2. G.R. Marshall The conformational parameter in drug design: the active analog approach E.C. Olson, R.E. Christoffersen, Computer-Assisted Drug Design 1979 American Chemical Society 205 226
3. A.R. Leach Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 53 2010 539 558
4. P.J. Goodford A computational procedure for determining energetically favorable binding sites on biologically important macromolecules J. Med. Chem. 28 1985 849 857
5. Molecular Discovery: http://www.moldiscovery.com
6. S. Cross Molecular fields in drug discovery: getting old or reaching maturity? Drug Discov. Today 15 2010 23 32
7. I.D. Kuntz A geometric approach to macromolecule-ligand interactions J. Mol. Biol. 161 1982 269 288
8. G. Bottegoni Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking J. Med. Chem. 52 2009 397 406
9. A.N. Jain J Comput.-Aided Mol. Des. 23 2009 355 374
10. R.W Cristiano Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap Method and free energy perturbation calculations J. Chem. Inf. Model. 50 2010 547 559
11. B. Waszkowycz Towards improving compound selection in structure-based virtual screening Drug Discov. Today 13 2008 219 226
12. D.E. Clark What has virtual screening ever done for drug discovery? Expert Opin. Drug Discov. 3 2008 841 851
13. N. Huang Benchmarking sets for molecular docking J. Med. Chem. 49 2006 6789 6801
14. R.D. Clark, and D.J. Webster-Clark Managing bias in ROC curves J. Comput.-Aided Mol. Des. 22 2008 141 146
15. A.N. Jain Recommendations for evaluation of computational methods J. Comput.-Aided Mol. Des. 22 2008 133 139
16. A.C. Good Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? J. Comput.-Aided Mol. Des. 22 2008 169 178
17. A. Nicholls What do we know and when do we know it? J. Comput.-Aided Mol. Des. 22 2008 239 255
18. M. Baroni A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): theory and application J. Chem. Inf. Model. 47 2007 279 294
19. S. Cross FLAP: GRID molecular interaction fields in virtual screening: validation using the DUD dataset J. Chem. Inf. Model. 50 2010 1442 1450
20. S. Sciabola High-throughput virtual screening of proteins using GRID molecular interaction fields J. Chem. Inf. Model. 50 2010 155 169
21. C. Tintori Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery J. Chem. Inf. Model. 48 2008 2166 2179
22. J. Chen Pocket v.2: further developments on receptor-based pharmacophore modeling J. Chem. Inf. Model. 46 2006 2684 2691
23. F. Ortuso GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition Bioinformatics 22 2006 1449 1455
24. Accelrys: http://www.accelrys.com/
25. S. Alcaro Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients Curr. Med. Chem. 17 2010 290 308
26. F. Falchi 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors Chem. Med. Chem. 4 2009 976 987
27. Cambridge Crystallographic Data Centre: http://www.ccdc.cam.ac.uk/
28. M. Kołaczkowski Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity J. Med. Chem. 49 2006 6732 6741
29. G. Cruciani MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist J. Med. Chem. 48 2005 6970 6979
30. F. Fontaine Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors J. Med. Chem. 48 2005 2687 2694
31. MetaSite: http://www.moldiscovery.com/soft-metasite.php
32. A. Tarcsay Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach J. Comput.-Aided Mol. Des. 24 2010 399 408
33. P. Kirkpatrick Drug metabolism: seeking the soft spots Nature Rev. Drug Discov. 8 2009 196